Literature DB >> 3161629

Growth-coupled changes in glucosaminoglycans (heparan sulfate and hyaluronic acid) in normal and transformed human fibroblasts.

K Matuoka, Y Mitsui, S Murota.   

Abstract

Changes in glycosaminoglycans (GAGs) were investigated in relation to cell density, growth and transformation of human fibroblasts. Relative amounts (percentages of the total GAGs) of heparan sulfate (HS) increased and those of hyaluronic acid (HA) decreased in growth-reduced (serum-starved, exogenous HS-treated and dense) cultures of normal (WI-38) cells. In contrast, transformed (WI-38 CT-1) cells exerted such GAG changes only in serum-starved cultures, but not in HS-treated or dense cultures. These results indicate that the changes in glucosaminoglycans (G1cAGs) (HS and HA) is coupled exclusively with cell growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161629     DOI: 10.1016/0309-1651(85)90023-2

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  4 in total

1.  Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt.

Authors:  Jingdong Qin; Evgeny Berdyshev; Christophe Poirer; Nancy B Schwartz; Glyn Dawson
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

2.  Increased hyaluronate synthesis is required for fibroblast detachment and mitosis.

Authors:  M Brecht; U Mayer; E Schlosser; P Prehm
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

3.  Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.

Authors:  S L Schor; A M Schor; A M Grey; J Chen; G Rushton; M E Grant; I Ellis
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

4.  Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction.

Authors:  K Matuoka; M Namba; Y Mitsui
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.